The role of sleep in neurodevelopmental plasticity and emotion dysregulation in youth

NIH RePORTER · NIH · F31 · $48,974 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY Emotion dysregulation, defined as the inability to regulate the intensity and quality of emotions, is a common transdiagnostic symptom of mood disorders in early adolescence and a major risk factor for youth suicide. Evidence indicates that sleep disruption may be a driver of emotion dysregulation, and that sleep indices such as poor sleep efficiency – a greater time spent awake during attempted sleep – both precede and predict the onset of mood disorders. It is therefore critical to understand the neurodevelopmental mechanisms through which sleep disruption relates to emotion dysregulation during adolescence. Prior studies have linked alterations in the Default Mode Network (DMN) to both sleep disruption and emotion dysregulation. In parallel, findings indicate that sleep significantly impacts synaptic plasticity mechanisms crucial for brain maturation. Importantly, the protracted maturational program of the DMN may render this network particularly vulnerable to sleep disruption during adolescence; however, this has not been directly tested. Recent methodological advances provide a strong premise for the relevance of low frequency fMRI fluctuation amplitude as a non-invasive marker of developmental plasticity. Using this measure, our lab recently demonstrated a period of increased plasticity in the DMN during early to mid-adolescence, indicating that the DMN is highly malleable during this period. However, no work has comprehensively characterized the impact of sleep disruption on DMN developmental plasticity and emotion dysregulation in humans. In response to this gap, the current proposal will test the overarching hypothesis that poor sleep efficiency in early to mid-adolescence blunts developmental plasticity in the DMN and is associated with emotion dysregulation. To test this, the current proposal will apply advanced neuroimaging approaches to two complementary datasets. In Aim 1, cross-sectional relationships between sleep efficiency, emotion dysregulation, and DMN plasticity will be defined in a prospectively collected sample (ages 11-16) of 100 individuals with mood disorders and 50 typically developing comparators. This sample will include high-precision phenotyping not available in large-scale data, including digital phenotyping of emotion regulation and next generation multi-echo fMRI sequences that enhance sensitivity. Aim 2 will delineate how sleep efficiency impacts longitudinal development of plasticity in the DMN and emotion dysregulation by leveraging the large-scale longitudinal Adolescent Brain Cognitive Development (ABCD) Study (ages 11-16). Both datasets will include wristwatch-recorded sleep, providing objective measures of sleep efficiency. Taken together, findings will provide critical new insights into the neurodevelopmental underpinnings of sleep disruption and emotion dysregulation. Supported by a strong mentorship team with complementary expertise (Drs. Satterthwaite, Mackey, Gehrman, Shou, and Barch) ...

Key facts

NIH application ID
11070453
Project number
1F31MH136685-01A1
Recipient
UNIVERSITY OF PENNSYLVANIA
Principal Investigator
Joelle Bagautdinova
Activity code
F31
Funding institute
NIH
Fiscal year
2024
Award amount
$48,974
Award type
1
Project period
2024-09-01 → 2027-08-31